BCL10 antibody (C-Term)
Quick Overview for BCL10 antibody (C-Term) (ABIN2209042)
Target
See all BCL10 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Sequence
- EMFLPLRSRT VSRQC
-
Cross-Reactivity
- Human
-
Cross-Reactivity (Details)
- Calculated cross reactivity: Hu
-
Characteristics
- Bcl 10 (B Cell Leukemia 10, CIPER, mE10, CARMEN, CLAP)
-
Purification
- Purified by immunoaffinity chromatography.
-
Immunogen
- C-terminal sequence [EMFLPLRSRTVSRQC] of Bcl10.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.01 % sodium azide before the addition of 40 % glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- 4°C (-20°C Glycerol)
-
-
- BCL10 (B-Cell CLL/lymphoma 10 (BCL10))
-
Alternative Name
- Bcl 10
-
Pathways
- TCR Signaling, Fc-epsilon Receptor Signaling Pathway, Activation of Innate immune Response, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Tube Formation, Positive Regulation of Endopeptidase Activity, BCR Signaling, Ubiquitin Proteasome Pathway, S100 Proteins
Target
-